Literature DB >> 17456782

Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors.

Norman L Lehman1, Rob Tibshirani, Jerry Y Hsu, Yasodha Natkunam, Brent T Harris, Robert B West, Marilyn A Masek, Kelli Montgomery, Matt van de Rijn, Peter K Jackson.   

Abstract

The fidelity of cell division is dependent on the accumulation and ordered destruction of critical protein regulators. By triggering the appropriately timed, ubiquitin-dependent proteolysis of the mitotic regulatory proteins securin, cyclin B, aurora A kinase, and polo-like kinase 1, the anaphase promoting complex/cyclosome (APC/C) ubiquitin ligase plays an essential role in maintaining genomic stability. Misexpression of these APC/C substrates, individually, has been implicated in genomic instability and cancer. However, no comprehensive survey of the extent of their misregulation in tumors has been performed. Here, we analyzed more than 1600 benign and malignant tumors by immunohistochemical staining of tissue microarrays and found frequent overexpression of securin, polo-like kinase 1, aurora A, and Skp2 in malignant tumors. Positive and negative APC/C regulators, Cdh1 and Emi1, respectively, were also more strongly expressed in malignant versus benign tumors. Clustering and statistical analysis supports the finding that malignant tumors generally show broad misregulation of mitotic APC/C substrates not seen in benign tumors, suggesting that a "mitotic profile" in tumors may result from misregulation of the APC/C destruction pathway. This profile of misregulated mitotic APC/C substrates and regulators in malignant tumors suggests that analysis of this pathway may be diagnostically useful and represent a potentially important therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17456782      PMCID: PMC1854971          DOI: 10.2353/ajpath.2007.060767

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  56 in total

Review 1.  CDK inhibitors: positive and negative regulators of G1-phase progression.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

2.  Emi1 stably binds and inhibits the anaphase-promoting complex/cyclosome as a pseudosubstrate inhibitor.

Authors:  Julie J Miller; Matthew K Summers; David V Hansen; Maxence V Nachury; Norman L Lehman; Alex Loktev; Peter K Jackson
Journal:  Genes Dev       Date:  2006-08-18       Impact factor: 11.361

3.  Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb.

Authors:  J Jiang; G Struhl
Journal:  Nature       Date:  1998-01-29       Impact factor: 49.962

4.  A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers.

Authors:  J R Bischoff; L Anderson; Y Zhu; K Mossie; L Ng; B Souza; B Schryver; P Flanagan; F Clairvoyant; C Ginther; C S Chan; M Novotny; D J Slamon; G D Plowman
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

5.  Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase.

Authors:  M R Smith; M L Wilson; R Hamanaka; D Chase; H Kung; D L Longo; D K Ferris
Journal:  Biochem Biophys Res Commun       Date:  1997-05-19       Impact factor: 3.575

6.  Deregulated cyclin E induces chromosome instability.

Authors:  C H Spruck; K A Won; S I Reed
Journal:  Nature       Date:  1999-09-16       Impact factor: 49.962

7.  Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast.

Authors:  T Tanaka; M Kimura; K Matsunaga; D Fukada; H Mori; Y Okano
Journal:  Cancer Res       Date:  1999-05-01       Impact factor: 12.701

8.  Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis.

Authors:  H Zou; T J McGarry; T Bernal; M W Kirschner
Journal:  Science       Date:  1999-07-16       Impact factor: 47.728

9.  Mutations of mitotic checkpoint genes in human cancers.

Authors:  D P Cahill; C Lengauer; J Yu; G J Riggins; J K Willson; S D Markowitz; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

10.  Exogenous expression of beta-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest.

Authors:  K Orford; C C Orford; S W Byers
Journal:  J Cell Biol       Date:  1999-08-23       Impact factor: 10.539

View more
  57 in total

1.  Identification and Testing of Novel CARP-1 Functional Mimetic Compounds as Inhibitors of Non-Small Cell Lung and Triple Negative Breast Cancers.

Authors:  Magesh Muthu; Jaganmohan Somagoni; Vino T Cheriyan; Sara Munie; Edi Levi; Abdelkader E Ashour; Alaa Eldeen B Yassin; Ahmed M Alafeefy; Paula Sochacki; Lisa A Polin; Kaladhar B Reddy; Scott D Larsen; Mandip Singh; Arun K Rishi
Journal:  J Biomed Nanotechnol       Date:  2015-09       Impact factor: 4.099

2.  Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas.

Authors:  Norman L Lehman; James P O'Donnell; Lisa J Whiteley; Robert T Stapp; Trang D Lehman; Kathleen M Roszka; Lonni R Schultz; Caitlin J Williams; Tom Mikkelsen; Stephen L Brown; Jeffrey A Ecsedy; Laila M Poisson
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

3.  FZR1 loss increases sensitivity to DNA damage and consequently promotes murine and human B-cell acute leukemia.

Authors:  Jo Ishizawa; Eiji Sugihara; Shinji Kuninaka; Kaoru Mogushi; Kensuke Kojima; Christopher B Benton; Ran Zhao; Dhruv Chachad; Norisato Hashimoto; Rodrigo O Jacamo; Yihua Qiu; Suk Young Yoo; Shinichiro Okamoto; Michael Andreeff; Steven M Kornblau; Hideyuki Saya
Journal:  Blood       Date:  2017-01-31       Impact factor: 22.113

Review 4.  APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis.

Authors:  Morgan S Schrock; Benjamin R Stromberg; Luke Scarberry; Matthew K Summers
Journal:  Semin Cancer Biol       Date:  2020-03-09       Impact factor: 15.707

5.  Antagonists of anaphase-promoting complex (APC)-2-cell cycle and apoptosis regulatory protein (CARP)-1 interaction are novel regulators of cell growth and apoptosis.

Authors:  Vineshkumar Thidil Puliyappadamba; Wenjuan Wu; Debra Bevis; Liyue Zhang; Lisa Polin; Robert Kilkuskie; Russell L Finley; Scott D Larsen; Edi Levi; Fred R Miller; Anil Wali; Arun K Rishi
Journal:  J Biol Chem       Date:  2011-09-08       Impact factor: 5.157

Review 6.  Functional characterization of Anaphase Promoting Complex/Cyclosome (APC/C) E3 ubiquitin ligases in tumorigenesis.

Authors:  Jinfang Zhang; Lixin Wan; Xiangpeng Dai; Yi Sun; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-02-22

7.  Differential expression of aurora-A kinase in T-cell lymphomas.

Authors:  Rashmi Kanagal-Shamanna; Norman L Lehman; James P O'Donnell; Megan S Lim; Daniel S Schultz; Dhananjay A Chitale; Carlos E Bueso-Ramos; L Jeffrey Medeiros; Kedar V Inamdar
Journal:  Mod Pathol       Date:  2013-02-15       Impact factor: 7.842

Review 8.  Roles of F-box proteins in cancer.

Authors:  Zhiwei Wang; Pengda Liu; Hiroyuki Inuzuka; Wenyi Wei
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

Review 9.  The ubiquitin proteasome system in neuropathology.

Authors:  Norman L Lehman
Journal:  Acta Neuropathol       Date:  2009-07-14       Impact factor: 17.088

10.  The onconeural antigen cdr2 is a novel APC/C target that acts in mitosis to regulate c-myc target genes in mammalian tumor cells.

Authors:  Kevin J O'Donovan; Jennifer Diedler; Graeme C Couture; John J Fak; Robert B Darnell
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.